|
The BBC (1), BMJ (2), EFGCP (3), ICR (4), MRC (5)- everyone is joining the
debate. The EU Directive will either kill or save non-commercial clinical
research.
Everyone agrees we want high quality, robust clinical
trials into needy therapeutic areas. This research is required regardless
of whether the end results would lead to a commercial project.
At midian, our focus has always been; how can we further
support crucial non-commercial clinical research?
We want to share our expertise and knowledge with the
non-commercial arena.
The midian roadmap for supporting non-commercial clinical
studies:
|